EMEA-002266-PIP01-17
Key facts
Active substance |
Recombinant human acid ceramidase (RVT-801)
|
Therapeutic area |
Other
|
Decision number |
P/0319/2018
|
PIP number |
EMEA-002266-PIP01-17
|
Pharmaceutical form(s) |
Solution for infusion
|
Condition(s) / indication(s) |
Farber disease
|
Route(s) of administration |
Intravenous use
|
Contact for public enquiries |
Aceragen Inc.
Tel. +15182583364 |
Decision type |
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
|